@article{b4bbdb945901488b867795d9da3bb01c,
title = "Tobramycin dosing in cystic fibrosis",
keywords = "aminoglycoside antibiotic agent, ceftazidime, tobramycin, acute kidney failure, antibiotic resistance, clinical trial, cystic fibrosis, drug dose regimen, human, letter, minimum inhibitory concentration, nephrotoxicity, priority journal, Pseudomonas aeruginosa, sputum culture",
author = "Alan Smyth and Daan Touw and Tan, {Kelvin H-V} and Carol Bertenshaw and David Stableforth",
year = "2005",
month = may,
doi = "10.1016/S0140-6736(05)66577-4",
language = "English",
volume = "365",
pages = "1767--1768",
journal = "The Lancet",
issn = "0140-6736",
publisher = "ELSEVIER SCIENCE INC",
number = "9473",
}